Literature DB >> 9724385

Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringes.

R Bartosch1, S Granegger, H Sinzinger.   

Abstract

Some groups have reported that adsorption of radiopharmaceuticals on disposable plastic syringes can reach levels of almost 50%. This high loss of radioactivity stimulated us to carry out similar studies. Our measurements were done in combination with patient studies. Therefore, we used 2-ml syringes, all of the same brand. The radioactivity in the syringe was measured immediately before and after injection. a total of 500-600 MBq technetium-99m labelled tetrofosmin or technetium-99m furifosmin was administered to 48 patients using four different injection techniques (n = 6 for each technique with each tracer): with needles, 1 min blood incubation at 22 degrees C, 10 or 30 min after preparation of the tracer; with butterflies, 1 min blood incubation at 22 degrees C, 10 or 30 min after preparation of the tracer. Neither in syringes nor in needles or butterflies did more than 7% of the initial radioactivity remain. The entire residual activity in syringe plus needle or syringe plus butterfly together never exceeded the 9% limit. Furthermore, in a pilot study we measured the remaining radioactivity in the vial; here, too, we found no more than 14% of total radioactivity. These findings indicate that total retention of radioactivity during elution and application of 99mTc-tetrofosmin and 99mTc-furifosmin with material used in our setting does not approach relevant amounts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724385     DOI: 10.1007/s002590050304

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  2 in total

1.  Tc-99m adherence and dose reduction in myocardial perfusion imaging.

Authors:  Pravin V Patil
Journal:  J Nucl Cardiol       Date:  2015-09-24       Impact factor: 5.952

2.  Adherence of Tc-99 Sestamibi to Plastic Syringes Could Complicate Efforts in Dose Reduction in MPI SPECT.

Authors:  Sean N Reynolds; Janusz Kikut
Journal:  J Nucl Cardiol       Date:  2015-08-26       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.